News

MorphoSys plans to reveal the target molecule of its lead antibody program MOR103 and additional information on the design of the Phase I clinical study on January 16,

Mr Shatar has completed his LLB and bachelor of economics from Monash University, Melbourne, Australia. Mr Shatar most recently served as the managing director of ICI Paints Malaysia.

Curis will receive an initial payment of $1 million, which is net of a payment to be made by Curis to a former third-party collaborator of Creative BioMolecules,

In June 2003, Millennium entered into an agreement with Ortho Biotech Products to collaborate on the commercialization and continued clinical development of Velcade. Under the terms of the

The company said that the Livian cardiac resynchronization therapy defibrillator (CRT-D), which is available in high-energy and standard-energy models, enables clinicians to customize therapy based on a patient’s

Cetirizine hydrochloride is antihistamine drug, which is used to treat allergies, hives, and other allergic inflammatory conditions. These new products are bioequivalent to Zyrtec Allergy tablets and Zyrtec

Adolor and Pfizer are collaborating on the worldwide development and commercialization of two novel delta opioid agonist compounds, ADL5859 and ADL5747, for the treatment of pain. The delta

Argatroban is approved by the FDA for the treatment of heparin-induced thrombocytopenia. Encysive is the holder of the new drug application for Argatroban, and has licensed the North

The acquisition was completed in accordance with the merger agreement announced earlier among Plethico, Nutra Acquisition Company (MergerSub), a wholly owned subsidiary of Plethico, and Natrol, by means